(Press-News.org) Philadelphia, Pa. (February 20, 2014) - Abnormal color vision increases significantly with aging—affecting one-half or more of people in the oldest age groups, reports a study in Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
While few people younger than 70 have problems with color vision, the rate increases rapidly through later decades of life, according to the new research by Marilyn E. Schneck, PhD, and colleagues of The Smith-Kettlewell Eye Research Institute, San Francisco. They write, "We find the color discrimination declines with age and that the majority of color defects among the older population are of the blue-yellow type."
Color Vision Abnormalities Increase with Age
The researchers administered color vision tests to a random sample of 865 older adults—age range 58 to 102 years. The study excluded subjects with any type of congenital color-vision defect ("color blindness."). The types and rates of color vision abnormalities were assessed in different age groups.
Overall, 40 percent of the participants had abnormal results on one of the two color vision tests used in the study. Twenty percent failed both tests.
The failure rate was markedly higher in older age groups. Although color-vision abnormalities were uncommon in people younger than 70, they were present in about 45 percent of people in their mid-70s, up to 50 percent of those 85 and older, and nearly two-thirds of those in their mid-90s.
Nearly 80 percent of the abnormalities involved confusion of the lighter (pastel) shades of blue versus purple and yellow versus green and yellow-green. These "blue-yellow" errors are distinct from the "red-green" errors observed in people with inherited color blindness, which affects about eight percent of males and 0.5 percent of females. Although the two tests had different failure rates, they detected similar frequencies of blue-yellow errors.
More Severe Defects May Affect Daily Functioning
The results confirm previous studies showing that color vision "deteriorates measurably" with aging. Most subtle aging-related color vision abnormalities are likely to go unnoticed, the researchers suggest.
However, they note that nearly 20 percent of older adults failed the easier of the two tests, "designed to only detect defects sufficiently severe to affect performance in daily life." Dr Schneck and coauthors note, "These individuals would have problems carrying out some tasks that rely on color vision."
The researchers discuss factors that may contribute to changes in color vision with aging, and to blue-yellow defects in particular. These may include reduced pupil size, admitting less light into the eye; increased yellowing of the lens inside the eye; and changes in the sensitivity of the vision pathways. All of these are known changes with age to the human eye.
Increased rates of eye diseases are another potentially important contributor. Dr Schneck and coauthors add, "The most common age-related eye diseases (glaucoma, age-related macular degeneration, and diabetic eye disease) all produce blue-yellow color vision anomalies, at least in the preclinical or early stages."
INFORMATION:
About Optometry and Vision Science
Optometry and Vision Science, official journal of the American Academy of Optometry, is the most authoritative source for current developments in optometry, physiological optics, and vision science. This frequently cited monthly scientific journal has served primary eye care practitioners for more than 75 years, promoting vital interdisciplinary exchange among optometrists and vision scientists worldwide.
About the American Academy of Optometry
Founded in 1922, the American Academy of Optometry is committed to promoting the art and science of vision care through lifelong learning. All members of the Academy are dedicated to the highest standards of optometric practice through clinical care, education or research.
About Wolters Kluwer Health
Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries and territories worldwide, Wolters Kluwer Health's customers include professionals, institutions and students in medicine, nursing, allied health and pharmacy. Major brands include Health Language®, Lexicomp®, Lippincott Williams & Wilkins, Medicom®, Medknow, Ovid®, Pharmacy OneSource®, ProVation® Medical and UpToDate®.
Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2012 annual revenues of €3.6 billion ($4.6 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Follow our official Twitter handle: @WKHealth.
Color vision problems become more common with age, reports Optometry and Vision Science
Study finds color vision abnormalities in 40 percent of older adults
2014-02-20
ELSE PRESS RELEASES FROM THIS DATE:
Roots to shoots: Hormone transport in plants deciphered
2014-02-20
Plant growth is orchestrated by a spectrum of signals from hormones within a plant. A major group of plant hormones called cytokinins originate in the roots of plants, and their journey to growth areas on the stem and in leaves stimulates plant development. Though these phytohormones have been identified in the past, the molecular mechanism responsible for their transportation within plants was previously poorly understood.
Now, a new study from a research team led by biochemist Chang-Jun Liu at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory identifies ...
New research shows the way a room is lit can affect the way you make decisions
2014-02-20
The next time you want to turn down the emotional intensity before making an important decision, you may want to dim the lights first.
A new study from the University of Toronto Scarborough shows that human emotion, whether positive or negative, is felt more intensely under bright light. Alison Jing Xu, assistant professor of management at UTSC and the Rotman School of Management, along with Aparna Labroo of Northwestern University, conducted a series of studies to examine the unusual paradox of lighting and human emotion.
"Other evidence shows that on sunny days people ...
Recurrent mouth and throat cancers less deadly when caused by virus, study shows
2014-02-20
People with late-stage cancer at the back of the mouth or throat that recurs after chemotherapy and radiation treatment are twice as likely to be alive two years later if their cancer is caused by the human papillomavirus (HPV), new research led by a Johns Hopkins scientist suggests.
Previous studies have found that people with so-called HPV-positive oropharyngeal cancers are more likely to survive than those whose cancers are related to smoking or whose origins are unknown.
The new study, scheduled to be presented Feb. 20 at the 2014 Multidisciplinary Head and Neck ...
Humidification of the mouth, throat during RT for head and neck cancer reduces mucositis, hospital stay
2014-02-20
Scottsdale, Ariz., February 20, 2014—Patients who received daily humidification of the mouth and throat region beginning from day one of radiation therapy treatment spent nearly 50 percent fewer days in the hospital to manage their side effects, according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium.
The study was conducted by the Trans Tasman Radiation Oncology Group and evaluated 210 head and neck cancer patients in New Zealand and Australia from June 2007 through June 2011. Patients in this Phase III trial were randomized ...
HPV-positive OPSCC patients nearly twice as likely to survive as HPV-negative patients
2014-02-20
Scottsdale, Ariz., February 20, 2014—A retrospective analysis of oropharyngeal patients with recurrence of disease after primary therapy in the Radiation Therapy Oncology Group (RTOG) studies 0129 or 0522 found that HPV-positive patients had a higher overall survival (OS) rate than HPV-negative patients (at two years post-treatment, 54.6 percent vs. 27.6 percent, respectively), according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium.
The analysis included 181 patients with stage III-IV oropharyngeal squamous cell carcinoma (OPSCC) ...
HPV-positive SCCOP patients' recurrence differs from HPV-negative patients
2014-02-20
Scottsdale, Ariz., February 20, 2014—Patients with HPV-positive squamous cell carcinoma of the oropharynx (SCCOP) had a longer time to development of distant metastasis (DM) after initial treatment, and had more metastatic sites in more atypical locations compared to HPV-negative patients, according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium.
Culled from records of an IRB-approved registry, the study reviewed 285 patients with stage III-IV SCCOP (originally thought to be a smoking-related head and neck cancer) treated with ...
Feasible, safe to limit radiation to major salivary glands in head and neck cancer patients
2014-02-20
Scottsdale, Ariz., February 20, 2014—Avoiding the contralateral submandibular gland during radiation therapy is feasible and safe with advanced stage, node positive head and neck cancers and base of tongue lesions, according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium.
Researchers conducted a retrospective analysis of 71 patients from two facilities—the University of Colorado Cancer Center and the Memorial Sloan-Kettering Cancer Center. The median patient age was 55, and about 50 percent of the patients were current or former ...
Patients with oropharyngeal cancer report quality of voice and speech affected post-treatment
2014-02-20
Scottsdale, Ariz., February 20, 2014—Oropharyngeal cancer patients treated with combined chemotherapy and radiation therapy reported a decrease in their voice and speech quality (VSQ) for up to one year after the completion of treatment, according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium. The study further shows that limiting the dose of radiation to the glottic larynx (GL) to less than 20 Gy resulted in a decrease in post-treatment VSQ problems, and that patient-reported VSQ indicated more adverse effects from treatment compared ...
Reducing RT dose to bilateral IB lymph nodes results in better patient-reported salivary function
2014-02-20
Scottsdale, Ariz., February 20, 2014—For head and neck cancer patients undergoing radiation therapy, a reduction in the amount of radiation treatment volume to the submandibular (level IB) lymph nodes resulted in better patient-reported salivary function, according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium. The study results also found significant reductions in radiation dose to the salivary organs, and good local regional control.
Researchers evaluated 125 patients with node-positive oropharyngeal cancer who received chemoradiation ...
Unilateral radiation therapy for advanced stage tonsil cancer results in favorable outcomes
2014-02-20
Scottsdale, Ariz., February 20, 2014—Limiting radiation therapy to lymph nodes on one side of the neck for advanced tonsil cancer resulted in good local regional control and no cancer recurrence on the untreated side, according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium. Additionally, the study results indicate that primary tumor location, rather than the amount of lymph node involvement on the tumor side of the neck, dictates the risk for disease in the opposite side of the neck.
The study focused on 46 out of 153 total patients ...
LAST 30 PRESS RELEASES:
Final data and undiscovered images from NASA’s NEOWISE
Nucleoporin93: A silent protector in vascular health
Can we avert the looming food crisis of climate change?
Alcohol use and antiobesity medication treatment
Study reveals cause of common cancer immunotherapy side effect
New era in amphibian biology
Harbor service, VAST Data provide boost for NCSA systems
New prognostic model enhances survival prediction in liver failure
China focuses on improving air quality via the coordinated control of fine particles and ozone
Machine learning reveals behaviors linked with early Alzheimer’s, points to new treatments
Novel gene therapy trial for sickle cell disease launches
Engineering hypoallergenic cats
Microwave-induced pyrolysis: A promising solution for recycling electric cables
Cooling with light: Exploring optical cooling in semiconductor quantum dots
Breakthrough in clean energy: Scientists pioneer novel heat-to-electricity conversion
Study finds opposing effects of short-term and continuous noise on western bluebird parental care
Quantifying disease impact and overcoming practical treatment barriers for primary progressive aphasia
Sports betting and financial market data show how people misinterpret new information in predictable ways
Long COVID brain fog linked to lung function
Concussions slow brain activity of high school football players
Study details how cancer cells fend off starvation and death from chemotherapy
Transformation of UN SDGs only way forward for sustainable development
New study reveals genetic drivers of early onset type 2 diabetes in South Asians
Delay and pay: Tipping point costs quadruple after waiting
Magnetic tornado is stirring up the haze at Jupiter's poles
Cancers grow uniformly throughout their mass
Researchers show complex relationship between Arctic warming and Arctic dust
Brain test shows that crabs process pain
Social fish with low status are so stressed out it impacts their brains
Predicting the weather: New meteorology estimation method aids building efficiency
[Press-News.org] Color vision problems become more common with age, reports Optometry and Vision ScienceStudy finds color vision abnormalities in 40 percent of older adults